Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Crataegus monogyna
Hawthorn is a thorny shrub or tree whose berries, leaves, and flowers have been used in European herbal medicine for centuries for cardiovascular health. It is one of the most well-studied herbs for heart failure and is approved by the German Commission E for declining cardiac performance. It is rich in flavonoids and procyanidins.
Hawthorn (Crataegus spp., primarily C. laevigata and C. monogyna) has Level A evidence for chronic heart failure (NYHA I-II). Standardized leaf/flower extracts (WS 1442, LI 132) improve cardiac function, exercise tolerance, and reduce symptoms. The mechanism involves multiple cardiac effects: mild positive inotropic, coronary vasodilation, and antioxidant protection. Hawthorn is the most studied botanical for cardiovascular disease in Europe, with over 7,000 patients in clinical trials.
Flavonoids (hyperoside, vitexin, rutin), oligomeric procyanidins (OPC), and triterpenes are the primary actives. Multiple cardiac mechanisms: (1) Inhibition of phosphodiesterase-3 (PDE3), increasing cAMP and calcium availability (mild positive inotropy); (2) Coronary vasodilation via NO release; (3) ACE inhibition, reducing afterload; (4) Antioxidant protection of myocardial cells; (5) Antiarrhythmic effects. Unlike digoxin, hawthorn's effects are modest and not associated with toxicity. The multi-component nature creates synergistic cardiac benefits.
Hawthorn is a thorny shrub or tree whose berries, leaves, and flowers have been used in European herbal medicine for centuries for cardiovascular health. It is one of the most well-studied herbs for heart failure and is approved by the German Commission E for declining cardiac performance. It is rich in flavonoids and procyanidins.
Hawthorn (Crataegus spp., primarily C. laevigata and C. monogyna) has Level A evidence for chronic heart failure (NYHA I-II). Standardized leaf/flower extracts (WS 1442, LI 132) improve cardiac function, exercise tolerance, and reduce symptoms. The mechanism involves multiple cardiac effects: mild positive inotropic, coronary vasodilation, and antioxidant protection. Hawthorn is the most studied botanical for cardiovascular disease in Europe, with over 7,000 patients in clinical trials.
Flavonoids (hyperoside, vitexin, rutin), oligomeric procyanidins (OPC), and triterpenes are the primary actives. Multiple cardiac mechanisms: (1) Inhibition of phosphodiesterase-3 (PDE3), increasing cAMP and calcium availability (mild positive inotropy); (2) Coronary vasodilation via NO release; (3) ACE inhibition, reducing afterload; (4) Antioxidant protection of myocardial cells; (5) Antiarrhythmic effects. Unlike digoxin, hawthorn's effects are modest and not associated with toxicity. The multi-component nature creates synergistic cardiac benefits.